Couragene
Novel Delivery Platforms, Breakthrough Therapies
- Website
- couragene.com
- Total Funding
- $40.0M
- Last Round
- $40.0M GrantSep 2024
- Rounds
- 1
About
Couragene develops gene and biologic therapies using proprietary delivery platforms intended to address the difficulty of delivering genetic medicines to targeted cells in vivo. Its work spans non-viral delivery of genome-editing machinery, DNA, RNA, and other biologics. The biotechnology company is advancing disease programs and aims to make genetic-medicine delivery safer and more efficient.
Summary
Couragene is a Biotech company. It has raised $40.0M in total across 1 round, most recently a $40.0M Grant round in Sep 2024.
Funding History
Sep 2024
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/couragene"><img src="https://indexed.vc/api/badge/company/couragene" alt="Couragene on Indexed.vc" width="260" height="76" /></a>